13F HOLDINGS REPORT
TCG Crossover Management, LLC
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001214659-26-001871
Total Value
$3.02B
Positions
43
Other Managers
0
Confidential Omitted
No
Holdings (43)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ABIVAX SA AMERICAN DEPOSITARY SHARES | AAVXF | 7,111,596 | $959.0M | 31.74% |
| 2 | COGENT BIOSCIENCES INC | COGT | 5,868,162 | $208.4M | 6.90% |
| 3 | CG ONCOLOGY INC | CGON | 3,670,206 | $152.4M | 5.04% |
| 4 | TANGO THERAPEUTICS INC | TNGX | 12,762,094 | $113.1M | 3.74% |
| 5 | CENTESSA PHARMACEUTICALS PLC | CNTA | 4,286,480 | $107.2M | 3.55% |
| 6 | DYNE THERAPEUTICS INC | DYN | 4,615,144 | $90.3M | 2.99% |
| 7 | RAPT THERAPEUTICS INC | 75382E208 | 2,582,408 | $87.5M | 2.89% |
| 8 | TYRA BIOSCIENCES INC | TYRA | 2,898,103 | $76.2M | 2.52% |
| 9 | AMYLYX PHARMACEUTICALS INC | AMLX | 6,243,812 | $75.4M | 2.50% |
| 10 | SAVARA INC | SVRA | 12,362,205 | $74.5M | 2.47% |
| 11 | MONTE ROSA THERAPEUTICS INC | GLUE | 4,622,151 | $72.5M | 2.40% |
| 12 | OCULAR THERAPEUTIX INC | OCUL | 5,740,231 | $69.7M | 2.31% |
| 13 | DIANTHUS THERAPEUTICS INC | DNTH | 1,676,624 | $69.1M | 2.29% |
| 14 | EYEPOINT PHARMACEUTICALS INC | EYPT | 3,572,335 | $65.3M | 2.16% |
| 15 | STRUCTURE THERAPEUTICS INC | GPCR | 920,857 | $64.0M | 2.12% |
| 16 | SPYRE THERAPEUTICS INC | SYRE | 1,900,582 | $62.3M | 2.06% |
| 17 | FULCRUM THERAPEUTICS INC | FULC | 5,250,000 | $59.4M | 1.97% |
| 18 | LIQUIDIA TECHNOLOGIES INC | LQDA | 1,710,084 | $59.0M | 1.95% |
| 19 | BIOHAVEN LTD | BHVN | 4,631,317 | $52.3M | 1.73% |
| 20 | IMMUNOVANT INC | IMVT | 1,660,933 | $42.2M | 1.40% |
| 21 | KODIAK SCIENCES INC | KOD | 1,445,538 | $40.4M | 1.34% |
| 22 | ADC THERAPEUTICS SA | ADCT | 11,390,175 | $40.2M | 1.33% |
| 23 | LB PHARMACEUTICALS INC | LBRX | 1,745,015 | $38.8M | 1.29% |
| 24 | XENCOR INC | XNCR | 2,452,138 | $37.5M | 1.24% |
| 25 | REVOLUTION MEDICINES INC | RVMDW | 436,473 | $34.8M | 1.15% |
| 26 | AGIOS PHARMACEUTICALS INC | AGIO | 1,181,841 | $32.2M | 1.06% |
| 27 | ARVINAS HOLDING CO LLC | ARVN | 2,666,216 | $31.6M | 1.05% |
| 28 | RELAY THERAPEUTICS INC | RLAY | 3,220,186 | $27.2M | 0.90% |
| 29 | JANUX THERAPEUTICS INC | JANX | 1,789,617 | $24.7M | 0.82% |
| 30 | ENTRADA THERAPEUTICS INC | TRDA | 2,088,392 | $21.5M | 0.71% |
| 31 | MBX BIOSCIENCES INC | MBX | 650,000 | $20.5M | 0.68% |
| 32 | UPSTREAM BIO INC | UPB | 743,886 | $20.2M | 0.67% |
| 33 | SILENCE THERAPEUTICS PLC | SLNCF | 3,033,560 | $18.4M | 0.61% |
| 34 | UROGEN PHARMA LTD | URGN | 717,347 | $16.8M | 0.56% |
| 35 | ALECTOR INC | ALEC | 10,000,000 | $15.6M | 0.52% |
| 36 | MONOPAR THERAPEUTICS INC | MNPR | 141,915 | $9.3M | 0.31% |
| 37 | AVALO THERAPEUTICS INC | AVTX | 483,000 | $8.8M | 0.29% |
| 38 | MAZE THERAPEUTICS INC | MAZE | 173,816 | $7.2M | 0.24% |
| 39 | MIRUM PHARMACEUTICALS INC | MIRM | 62,049 | $4.9M | 0.16% |
| 40 | Athira Pharma, Inc. | 04746L203 | 464,398 | $3.3M | 0.11% |
| 41 | KORRO BIO INC | KRRO | 416,301 | $3.3M | 0.11% |
| 42 | VENTYX BIOSCIENCES INC | 92332V107 | 316,195 | $2.9M | 0.09% |
| 43 | VISTAGEN THERAPEUTICS INC | VTGN | 2,676,580 | $1.8M | 0.06% |